Status:
UNKNOWN
Efficacy of Nano-Ivermectin Impregnated Masks in Prevention of Covid-19 Among Healthy Contacts and Medical Staff
Lead Sponsor:
South Valley University
Conditions:
Covid-19
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Antiviral efficacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution wi...
Detailed Description
Antiviral effecacy of Ivermectin against Covid-19 in vitro was stated by many stusies all over the world with decreased effecacy in vivo so ,usage of masks impregnated into nano Ivermectin solution wi...
Eligibility Criteria
Inclusion
- health care personells and family contact of confirmed COVID-19 cases.
Exclusion
- refusal of participate to use the masks.
- pregnancy or lactation known hypersensitivity to ivermectin.
Key Trial Info
Start Date :
January 23 2021
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
March 28 2021
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT04723459
Start Date
January 23 2021
End Date
March 28 2021
Last Update
March 17 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Zaky Aref
Qina, Egypt, 83511